Hemp CBD Science
  • Home
  • About Us
    • About Us
    • Key Opinion Leaders
    • About the Endocannabinoid System
      • Cannabis
      • Cannabidiol (CBD)
      • The Endocannabinoid system
      • Endocannabinoid Deficiency
  • Disorders
    • Autoimmune Disorders
      • Rheumatoid Arthritis
      • Crohn’s Disease
      • Multiple Sclerosis
      • Chronic Autoimmune Myocarditis
      • Autoimmune Encephalomyelitis
    • Cancer-Related Symptoms
      • Pain
      • Anti Nausea
      • Appetite Stimulation
    • Neuroprotection
      • Chronic Traumatic Encephalopathy
      • Hepatic Encephalopathy
      • Parkinson’s Disease
      • Alzheimer’s/Dementia
      • Alcohol-Related Neurotoxicity
      • Epilepsy
    • Anxiety Disorders
      • Generalized Anxiety Disorder (GAD)
      • Post-Traumatic Stress Disorder (PTSD)
      • Social Anxiety Disorder (SAD)
      • Obsessive–compulsive disorder (OCD)
    • Cancer
      • Glioblastoma
      • Leukemia
      • Colorectal
      • Lung Cancer
      • Cervical cancer
      • Prostate Cancer
      • Melanoma
      • Breast Cancer
    • Gastrointestinal
      • Inflammatory Bowel Disease
      • Irritable Bowel Syndrome
      • Ulcerative Colitis
      • Crohn’s Disease
    • Sleep
      • Insomnia
    • Pain
      • Joint Pain
      • Neuropathic Pain
      • Acute Pain
      • Chronic Pain
  • Participate
    • Our Ongoing Study
    • Current Clinical Trials
    • Equine Study
      • Equine Study Enter Your Data
  • Videos
  • Research Blog
    • Science
    • News
    • Legal
  • Physician Guide
    • Dosing Suggestions
    • State Medical Board Guide
    • Safety, Side Effects & Drug Interactions
  • Contact
Select Page

The FDA Defers to Pharma, Nixes CBD as Dietary Supplement

by | Aug 23, 2021 | Uncategorized

ValidCare seeks volunteers for the final phase of expanded clinical study of CBD’s effect on the liver.

Read Full Article at: CBD Report The FDA Defers to Pharma, Nixes CBD as Dietary Supplement

Recent Posts

  • Cannabis Banking Today: Navigating Verification, Compliance, and Regulatory Change
  • Can NY’s Legal Stores Compete with an Eight-Billion-Dollar Illicit Market?
  • The Case for Outsourcing HR in Cannabis
  • The State of Ohio’s Cannabis Legal Landscape
  • An MSO’s Perspective on the New York Market

Categories

  • Legal
  • News
  • Science
  • Uncategorized

* The information is presented for educational purposes only. Hemp CBD Science provides this information to provide an understanding of the potential applications of cannabinoids. Links to third party websites do not constitute an endorsement of these organizations by us and none should be inferred. These statements have not been evaluated by the Food and Drug Administration. These products featured on this site are not intended to diagnose, treat, cure or prevent any disease. Consult your physician before beginning any exercise program. Please view our Privacy Policy for more information. Copyright, Hemp CBD Science. If you believe your have a copyright claim, click here. Material on Hemp CBD Science may not be reprinted without permission.

  • Facebook
  • X
© 2017 Hemp CBD Science. All Rights Reserved. Privacy Policy. Copyright Information.